Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01682616 |
|---|---|
| Brief Title: | A Phase 1b Study Evaluating the Safety and Tolerability of ABT-199 in Combination With Rituximab in Subjects With Relapsed Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma |
| First Submitted : | June 26, 2012 |
| First Submitted that Met QC Criteria : | September 7, 2012 |
| First Posted : | September 11, 2012 (Estimate) |
| Last Update Submitted that Met QC Criteria : | July 11, 2022 |
| Last Update Posted : | July 12, 2022 |